Table 7.
Base-case result and one-way sensitivity analyses
| Scenario | ∆ cost | ∆ effect (avoided bronchoscopy) | ICER (cost per avoided bronchoscopy) |
|---|---|---|---|
| Base case | − 47.66 | 0.9333 | − 51.06 |
| One-way sensitivity analyses | |||
| Using single-use bronchoscope (aScope™) in 5% of all VivaSight-DL cases (n = 30) | − 32.71 | 0.9500 | − 34.43 |
| Using single-use bronchoscope (aScope™) in 10% of all VivaSight-DL cases (n = 60) | − 17.76 | 0.9000 | − 19.73 |
| Using single-use bronchoscope (aScope™) in 15% of all VivaSight-DL cases (n = 90) | − 2.81 | 0.8500 | − 3.30 |
| Increasing annual number of procedures, n = 800 | − 41.22 | 0.9333 | − 44.17 |
| Increasing annual number of procedures, n = 1000 | − 103.30 | 0.9333 | − 110.68 |
| Increasing annual number of procedures, n = 1200 | − 168.02 | 0.9333 | − 180.03 |
| Decreasing maintenance costs by additional 10% (n = 600) | − 39.05 | 0.9333 | − 41.84 |
| Decreasing maintenance costs by additional 15% (n = 600) | − 34.75 | 0.9333 | − 37.23 |
| Decreasing maintenance costs by additional 20% (n = 600) | − 30.45 | 0.9333 | − 32.62 |
| Decreasing cost of VivaSight-DL by 10% (n = 600) | − 77.65 | 0.9333 | − 83.20 |
| Decreasing cost of VivaSight-DL by 20% (n = 600) | − 107.65 | 0.9333 | − 115.34 |
| Decreasing cost of VivaSight-DL by 30% (n = 600) | − 137.64 | 0.9333 | − 147.48 |
Costs are presented in $US
cDLT conventional double-lumen tube, DL double-lumen tube